-transparent.png){kind=logo}
Nonpharmacologic treatment using surgery or intracardiac catheter ablation can be used for several forms of supraventricular tachycardia. Surgery is highly successful in preventing recurrent tachyarrhythmias in patients with the Wolff-Parkinson-White syndrome and can be recommended as first-line treatment in several situations. Catheter ablation of the atrioventricular conduction system combined with an implanted ventricular pacemaker can offer substantial relief to selected patients with drug-refractory atrial fibrillation. Technical advances in catheter ablation will undoubtedly lead to more widespread use of this form of therapy in supraventricular tachycardia.
Related Publications
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
January 1983,
Archives des maladies du coeur et des vaisseaux,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
March 1982,
Revista medica de Chile,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
August 1986,
The American journal of cardiology,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
June 1986,
Journal of cardiac surgery,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
October 1977,
The American journal of cardiology,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
January 1980,
Journal of the Medical Association of Georgia,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
January 1982,
Klinische Padiatrie,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
February 1979,
Boletin de la Asociacion Medica de Puerto Rico,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
April 1982,
La Nouvelle presse medicale,
E N Prystowsky, and
D L Packer, and
J J Schier, and
J E Lowe
June 1991,
The New England journal of medicine,
